# CRISPR Therapeutics AG: Form DEF 14A, filed Apr 9, 2024

- Company: [CRISPR Therapeutics AG](/companies/crsp.md) (CIK 1674416)
- Form: DEF 14A
- Filed: 2024-04-09
- Accepted by EDGAR: Apr 9, 2024, 16:42 ET
- Period: 2024-05-30
- Accession: 0000950170-24-043025
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674416/000095017024043025/crsp-20240409.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674416/000095017024043025/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674416/000095017024043025/crsp-20240409.htm

Filed Apr 9, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-043025. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.